Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ViOptix, Inc. logo — company profile

ViOptix, Inc.

Founded 1999 United States Newark, United States 19 employees Convertible Note Total: $27.23M Biotechnology, Health Care +1

General Information

Company Name ViOptix, Inc.
Founded Year 1999
Location United States Newark, United States
Employees 19
Industries Biotechnology, Health Care, Manufacturing
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with ViOptix, Inc.. To contact ViOptix, Inc., visit vioptix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ViOptix, Inc. compare?

A PDF of ViOptix, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ViOptix, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ViOptix, Inc.

ViOptix, Inc. is a biotechnology and healthcare startup, established in 1999 in the United States. The company has developed a proprietary breakthrough technology called T.Ox Tissue Oximetry, enabling non-invasive, direct, real-time measurement of local tissue oxygen saturation. This groundbreaking innovation allows physicians to obtain accurate, real-time, direct measurement of tissue oxygen levels, enabling them to assess tissue health "on the spot". The applications of ViOptix's platform technology range from plastic surgery to peripheral vascular disease and critical care, allowing for intraoperative and postoperative tissue oxygen saturation monitoring, estimation of wound healing potential, and determination of tissue viability. In June 2010, ViOptix, Inc. secured a $2.83M Convertible Note investment. This funding marks an important milestone for the company, demonstrating investor confidence in its innovative technology and potential impact across various medical fields. The investment signifies support for ViOptix's mission to provide healthcare professionals with advanced tools for better patient care and outcomes. With its focus on cutting-edge biotechnology and healthcare solutions, ViOptix, Inc. presents a compelling opportunity for venture capitalists seeking to invest in transformative technologies with tangible and broad-reaching applications.

Business keywords: T.Ox technology, Tissue Oximetry, Plastic Surgery, Intraoperative Monitoring, Postoperative Monitoring, Wound Healing, Peripheral Vascular Disease, Critical Care, Healthcare Innovation, Oxygen Saturation Monitoring, FDA Clearance, Near Infrared Generators, Disposable Sensor Devices, Tissue Viability Assessment

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note $2.83M -
21 Jun 2010
Series E $3.00M -
25 Jan 2010
Series D $12.20M 4
Canadian Medical Discoveries Fund Channel Medical Partners Lincoln Funds International
Canadian Medical Discoveries Fund, Channel Medical Partners +2
10 Jan 2008
Series C $9.20M 4
Vivo Capital MDS Capital
Vivo Capital, MDS Capital +2
10 Nov 2004

ViOptix, Inc. Alternatives & Competitors

ViOptix, Inc. vs
Profusa
Profusa United States

Leading the development of biosensors to transform health and wellness by making our body's chemistr...

Convertible Note
54 employees
Biotechnology, Health Care
ViOptix, Inc. vs
Kent Imaging
Kent Imaging Canada

Advancing Tissue Assessment

Venture round
40 employees
Design, Health Care
Compare ViOptix, Inc. vs Kent Imaging
ViOptix, Inc. vs
SuperSonic Imagine
SuperSonic Imagine France

Innovations in Ultrasound.

Post-IPO Equity
165 employees
Biotechnology, Health Care

FAQ About ViOptix, Inc.

ViOptix has developed the proprietary breakthrough T.Ox Tissue Oximetry technology which enables non-invasive, direct, real-time measurement of local tissue oxygen saturation.The key benefit of the T.Ox technology is that it allows physicians, for the first time, to obtain accurate, real-time, direc...
ViOptix, Inc. was founded in 1999.
ViOptix, Inc. is headquartered in Newark, United States.
ViOptix, Inc. operates in Biotechnology, Health Care and Manufacturing. Its work centres on T.Ox technology, Tissue Oximetry, Plastic Surgery and Intraoperative Monitoring.
ViOptix, Inc. has approximately 19 employees.
ViOptix, Inc. has completed 4 funding rounds, raising a total of $27.23M. The latest funding stage is Convertible Note.
Top alternatives and competitors to ViOptix, Inc. include Profusa, Kent Imaging, SuperSonic Imagine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ViOptix, Inc. and Profusa are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ViOptix, Inc., https://bouncewatch.com/company/vioptix-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes